Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for Bertilimumab for the Treatment of Bullous Pemphigoid Pharmaceutical Investing
Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections Pharmaceutical Investing
BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine Pharmaceutical Investing
ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection Biotech Investing
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi® Pharmaceutical Investing
Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis Pharmaceutical Investing
Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics Biotech Investing
EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel Pharmaceutical Investing
